Results 291 to 300 of about 151,234 (305)

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

New England Journal of Medicine, 2014
Loïc Guillevin, Christian Pagnoux, Alexandre Karras   +2 more
exaly  

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients

Kidney International, 2017
Stephen P Mcadoo, Zdenka Hrušková, Amy Kang   +2 more
exaly  

Key advances in the clinical approach to ANCA-associated vasculitis

Nature Reviews Rheumatology, 2014
exaly  

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Annals of the Rheumatic Diseases, 2018
Pierre Charles, Benjamin Terrier
exaly  

Anca Duta

2008 11th International Conference on Optimization of Electrical and Electronic Equipment, 2008
openaire   +1 more source

EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

Annals of the Rheumatic Diseases
Bernhard Hellmich, Alvise Berti, Maria C Cid   +2 more
exaly  

Anca abdotta

2013
Adriano Ferrari, Sandro Reverberi, Maria Grazia Benedetti   +2 more
openaire   +1 more source

ANCA in lupus nephritis

Lupus, 2017
openaire   +2 more sources

Anca addotta

2013
Adriano Ferrari, Sandro Reverberi, Maria Grazia Benedetti   +2 more
openaire   +1 more source

30.12 ANCA-assoziierte Vaskulitiden (AAV) ANCA = antineutrophile zytoplasmatische Antikörper assoziierte Vaskulitiden ANCA-assoziierte Vaskulitiden AAV = ANCA-assoziierte Vaskulitiden

2013
openaire   +1 more source